Sachin Marulkar

1.4k total citations
28 papers, 943 citations indexed

About

Sachin Marulkar is a scholar working on Physiology, Physiology and Hematology. According to data from OpenAlex, Sachin Marulkar has authored 28 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 8 papers in Physiology and 8 papers in Hematology. Recurrent topics in Sachin Marulkar's work include Lysosomal Storage Disorders Research (12 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Calcium signaling and nucleotide metabolism (8 papers). Sachin Marulkar is often cited by papers focused on Lysosomal Storage Disorders Research (12 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Calcium signaling and nucleotide metabolism (8 papers). Sachin Marulkar collaborates with scholars based in United States, France and United Kingdom. Sachin Marulkar's co-authors include Donald E. Cutlip, Richard E. Kuntz, Donald S. Baim, Joseph M. Massaro, Ameet Bakhai, Neal S. Kleiman, John J. López, Kelly Maresh, Htut K. Win and Kalon K.L. Ho and has published in prestigious journals such as JAMA, Circulation and Blood.

In The Last Decade

Sachin Marulkar

28 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sachin Marulkar United States 12 578 459 179 176 127 28 943
Carlos M. de Castro United States 15 419 0.7× 485 1.1× 188 1.1× 228 1.3× 577 4.5× 65 1.3k
Manu Varma United States 15 405 0.7× 367 0.8× 90 0.5× 330 1.9× 125 1.0× 19 990
Chantal Bernard Canada 15 168 0.3× 60 0.1× 77 0.4× 22 0.1× 196 1.5× 44 741
Anaadriana Zakarija United States 15 86 0.1× 96 0.2× 23 0.1× 348 2.0× 50 0.4× 29 790
W. Huhmann Germany 7 295 0.5× 499 1.1× 154 0.9× 178 1.0× 189 1.5× 15 784
Yun‐Gyoo Lee South Korea 15 112 0.2× 84 0.2× 34 0.2× 119 0.7× 430 3.4× 72 942
S. Osanto Netherlands 12 216 0.4× 98 0.2× 19 0.1× 123 0.7× 249 2.0× 22 786
Hacı Mehmet Türk Türkiye 14 163 0.3× 87 0.2× 53 0.3× 44 0.3× 227 1.8× 75 708
Anna Spasiano Italy 21 77 0.1× 245 0.5× 113 0.6× 765 4.3× 107 0.8× 76 1.1k
Е Н Александрова Russia 11 45 0.1× 46 0.1× 65 0.4× 106 0.6× 44 0.3× 210 610

Countries citing papers authored by Sachin Marulkar

Since Specialization
Citations

This map shows the geographic impact of Sachin Marulkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sachin Marulkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sachin Marulkar more than expected).

Fields of papers citing papers by Sachin Marulkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sachin Marulkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sachin Marulkar. The network helps show where Sachin Marulkar may publish in the future.

Co-authorship network of co-authors of Sachin Marulkar

This figure shows the co-authorship network connecting the top 25 collaborators of Sachin Marulkar. A scholar is included among the top collaborators of Sachin Marulkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sachin Marulkar. Sachin Marulkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khambholja, Kapil, et al.. (2024). Prognostic value of tumour-associated regulatory T-cells as a biomarker in non-small cell lung cancer: a systematic review and meta-analysis. Systematic Reviews. 13(1). 233–233. 1 indexed citations
2.
3.
Burton, Barbara K., et al.. (2022). Long‐Term Sebelipase Alfa Treatment in Children and Adults With Lysosomal Acid Lipase Deficiency. Journal of Pediatric Gastroenterology and Nutrition. 74(6). 757–764. 11 indexed citations
4.
Vijay, Suresh, Anaïs Brassier, Arunabha Ghosh, et al.. (2021). Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies. Orphanet Journal of Rare Diseases. 16(1). 13–13. 18 indexed citations
5.
Burton, Barbara K., François Feillet, Katryn N. Furuya, Sachin Marulkar, & Manisha Balwani. (2021). Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: Final results of the ARISE study. Journal of Hepatology. 76(3). 577–587. 16 indexed citations
6.
Vijay, Suresh, Anaïs Brassier, Arunabha Ghosh, et al.. (2021). Correction to: Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies. Orphanet Journal of Rare Diseases. 16(1). 113–113. 10 indexed citations
7.
Malinová, Vĕra, Manisha Balwani, Reena Sharma, et al.. (2020). Sebelipase alfa for lysosomal acid lipase deficiency: 5‐year treatment experience from a phase 2 open‐label extension study. Liver International. 40(9). 2203–2214. 15 indexed citations
8.
Wilson, Don P., Mark Friedman, Sachin Marulkar, Tyler Hamby, & Éric Bruckert. (2018). Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency. Journal of clinical lipidology. 12(3). 604–614. 11 indexed citations
9.
Jones, Simon, Sandra Rojas-Caro, Anthony Quinn, et al.. (2017). Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study. Orphanet Journal of Rare Diseases. 12(1). 25–25. 56 indexed citations
10.
Wilson, Don E., et al.. (2016). Sebelipase Alfa Improves Atherogenic Measures In Adults And Children With Lysosomal Acid Lipase Deficiency. Journal of clinical lipidology. 10(3). 678–679. 1 indexed citations
11.
Ross, Leorah, Ana Cristina Puga, Gerald F. Cox, et al.. (2014). Eliglustat safety profile based on a pooled analysis of data from four trials in Gaucher disease type I. Molecular Genetics and Metabolism. 111(2). S90–S90. 4 indexed citations
12.
Micallef, Ivana N., Patrick J. Stiff, Edward A. Stadtmauer, et al.. (2013). Safety and efficacy of upfront plerixafor + G‐CSF versus placebo + G‐CSF for mobilization of CD34+ hematopoietic progenitor cells in patients ≥60 and <60 years of age with non‐Hodgkin's lymphoma or multiple myeloma. American Journal of Hematology. 88(12). 1017–1023. 27 indexed citations
13.
Micallef, Ivana N., et al.. (2010). Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide. Bone Marrow Transplantation. 46(3). 350–355. 42 indexed citations
14.
Stiff, Patrick J., Ivana N. Micallef, Auayporn Nademanee, et al.. (2010). Transplanted CD34+ Cell Dose Is Associated with Long-Term Platelet Count Recovery following Autologous Peripheral Blood Stem Cell Transplant in Patients with Non-Hodgkin Lymphoma or Multiple Myeloma. Biology of Blood and Marrow Transplantation. 17(8). 1146–1153. 90 indexed citations
15.
16.
17.
18.
Win, Htut K., Angel Caldera, Kelly Maresh, et al.. (2007). Clinical Outcomes and Stent Thrombosis Following Off-Label Use of Drug-Eluting Stents. JAMA. 297(18). 2001–2001. 258 indexed citations
19.
Charytan, David M. & Sachin Marulkar. (2006). Relationship of aortic atherosclerosis to acute renal failure following cardiac surgery. Journal of Nephrology. 19(5). 628–633. 1 indexed citations
20.
Baim, Donald S., Richard R. Heuser, Jeffrey J. Popma, et al.. (2004). Utility of the Safe-Cross–guided radiofrequency total occlusion crossing system in chronic coronary total occlusions (Results from the Guided Radio Frequency Energy Ablation of Total Occlusions Registry Study). The American Journal of Cardiology. 94(7). 853–858. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos M. de Castro Breakdown of academic impact, for papers by Manu Varma Breakdown of academic impact, for papers by Chantal Bernard Breakdown of academic impact, for papers by Anaadriana Zakarija Breakdown of academic impact, for papers by W. Huhmann Breakdown of academic impact, for papers by Yun‐Gyoo Lee Breakdown of academic impact, for papers by S. Osanto Breakdown of academic impact, for papers by Hacı Mehmet Türk Breakdown of academic impact, for papers by Anna Spasiano Breakdown of academic impact, for papers by Е Н Александрова
Rankless by CCL
2026